期刊文献+

E-cadherin与炎性乳腺癌关系的研究进展 被引量:4

Research Progress on Relationship between E-Cadherin and Inflammatory Breast Cancer
下载PDF
导出
摘要 细胞粘附分子是一类介导细胞与细胞、细胞与细胞外基质之间粘附作用的糖蛋白,在肿瘤的发生、发展、侵袭和转移中起着重要作用。存在于成人上皮细胞的上皮细胞钙粘蛋白(E-cadherin/E-cad)是钙粘蛋白家族的主要成员之一,也一种重要的细胞粘附分子,其主要作用是参与形成和维护正常细胞间的连接,与细胞的生长、分化、迁移、信息传递和稳定以及创伤的修复过程有关。E-cadherin也被认为是一种肿瘤抑制基因,与多种上皮恶性肿瘤的分化、侵袭、转移和预后相关,其表达下调在乳腺癌中是一种普遍现象,与乳腺癌的分化程度、淋巴结转移及预后均密切相关。炎性乳腺癌是一种高度恶性的局部晚期特殊类型的乳腺癌,患者大多死于局部组织侵袭和远处转移。研究表明,E-cadherin在炎性乳腺癌组织或细胞系中却呈与功能一致的强阳性表达,与炎性乳腺癌的浸润和转移过程密切相关。本文综述了E-cadherin与炎性乳腺癌关系的最新研究进展。 Cell adhesion molecule is a kind of glycoprotein, which mediates the adhesive interactions between cells and extracellular matrix and plays an important role in the oncogenesis, development, invasion and metastasis of tumors. Epithelialcadherin(E-cad) is a major member of cadherin family that exists in adult epithelial cells, and also an important kind of cell adhesion molecule. It is mainly involved in the formation and maintainance of normal cell junctions and associated with growth, differentiation, migration, information transfer as well as healing of wounds. E-cadherin is also considered as a kind of tumor suppressor gene which is associated with the differentiation, invasion, metastasis and prognosis of epitheliogenic malignant tumors. Downregulation of the expression of E-cadherin is common and related with degrees of differentiation, lymph node metastasis and prognosis of breast cancer. Inflammatory breast cancer (IBC) is a special kind of highly malignant and locally advanced breast cancer, and patients with IBC mainly die of local invasion and metastasis. It has been proved that both IBC tumor and cell lines strongly express E-cadherin, which are in accordance with its function and associated with the invasion and metastasis of IBC. This article is aimed to review the research progress on relationship between e-cadherin and inflammatory breast cancer.
出处 《肿瘤药学》 CAS 2012年第4期249-252,共4页 Anti-Tumor Pharmacy
关键词 上皮细胞钙粘蛋白 炎性乳腺癌 上皮间质转化 浸润 转移 E-cadherin Inflammatory breast cancer Epithelial-mesenchymal transition Invasion Metastasis
  • 相关文献

参考文献23

  • 1肖春花,龚芸,付丽.炎性乳腺癌分子研究及治疗进展[J].中华乳腺病杂志(电子版),2010,4(2):22-25. 被引量:3
  • 2Turashvili G,Bouchal J,Baumforth K. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis[J].BMC Cancer,2007.55.doi:10.1186/1471-2407-7-55.
  • 3李兰,杨红鹰.粘附分子E-cadherin在乳腺肿瘤中的异常表达及其意义[J].癌症进展,2008,6(2):135-140. 被引量:4
  • 4Rodriguez FJ,Lewis-Tuffin LJ,Anastasiadis PZ. E-cadherin's dark side:Possible role in tumor progression[J].Biochimica Et Biophysica Acta,2012,(01):23-31.
  • 5Van Roy F,Berx G. The cell-cell adhesion molecule E-cadherin[J].Cellular and Molecular Life Sciences,2008,(23):3756-3788.doi:10.1007/s10586-010-0141-8.
  • 6Wang YX,Jin G,Miao H. Integrins regulate VEcadherin and catenins:Dependence of this regulation on Src,but not on Ras[J].Proceedings of the National Academy of Sciences(USA),2006,(06):1774-1779.doi:10.1073/pnas.0510774103.
  • 7Mareel MM,Behrens J,Birchmeier W. Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice[J].International Journal of Cancer,1991,(06):922-928.doi:10.1002/ijc.2910470623.
  • 8时志民,柳继兴,刘惠民,王蕾,杨习星.乳腺癌中EBP50、E-cadherin和β-catenin的表达及意义[J].中国实验诊断学,2010,14(10):1558-1560. 被引量:7
  • 9Yanagisawa M,Anastasiadis PZ. p120 catenin is essential for mesenchymal cadherin-mediated regulation of cell motility and invasiveness[J].Journal of Cell Biology,2006,(07):1087-1096.doi:10.1083/jcb.200605022.
  • 10Thiery JP,Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions[J].Nature Reviews Molecular Cell Biology,2006,(02):131-142.doi:10.1038/nrm1835.

二级参考文献56

  • 1Colpaert CG,Verrmeulen PB,Benoy I,et al.Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression.Br J Cancer,2003,88;718-725.
  • 2Tomlinson JS,Alpaugh ML,Barsky SH,et al.An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.Cancer Res,2001,61:5231-5241.
  • 3Alpaugh ML,Tomlinson JS,Ye Y,et al.Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma.Am J Pathol,2002,161:619-628.
  • 4Bieche I,Lerebours F,Tozlu S,et al.Molecular profiling of inflammatory breast cancer:identification of a poor-prognosis gene expression signature.Clin Cancer Res,2004,10:6789-6795.
  • 5Van der Auwera I,Van Laere SJ,Van den Eynden GG,et al.Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.Clin Cancer Res,2004,10:7965-7971.
  • 6He Y,Rajantie I,Pajusola K,et al.Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels.Cancer Res,2005,65:4739-4746.
  • 7Kleer CG,Griffith KA,Sabel MS,et al.RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.Breast Cancer Res Treat,2005,93:101-110.
  • 8Kleer CG,Zhang Y,Pan Q,et al.WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.Breast Cancer Res,2004,6:R110-R115.
  • 9Van Laere S,Van der Auwera I,Van den Eynden G,et al.Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis.Br J Cancer,2007,97:165-174.
  • 10Van Laere SJ,Van der Auwera I,Van den Eynden GG,et al.NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation,secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation.Br J Cancer,2007,97;659-669.

共引文献15

同被引文献42

  • 1ZHANG Yun-gang DU Juan TIAN Xin-xia ZHONG Yan-feng FANG Wei-gang.Expression of E-cadherin,beta-catenin,cathepsin D,gelatinases and their inhibitors in invasive ductal breast carcinomas[J].Chinese Medical Journal,2007(18):1597-1605. 被引量:13
  • 2Li BD, Sicard MA, Ampil F, et al. Trimodal thera py for inflammatory breast cancer: a surgeon's perspective [J]. Oncology, 2010,79 ( 1/2 ) : 3-12.
  • 3Dawood S. Biology and management of inflammatory breast cancer [J]. Expert Rev Anticancer Ther, 2010,10(2) :209-220.
  • 4Arias-Pulido H, Chaher N, Gong Y, et al. Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer[J]. BMC Cancer,2012,12:298.
  • 5Kashiwagi S, Yashiro M, Takashima T,et al. Significance of E-cadherin expression in triple-negative breast cancer [J]. Br J Cancer, 2010,103 (2) : 249-255.
  • 6Lan C, Liu JM, Liu TW,et al. Erb-b2 amplification by fluorescence in situ hybridization in breast cancer specimens read as 2+ in analysis [J]. Am J Clin Pathol, 2005,124( 1 ) :97-102.
  • 7Gong Y. Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype [J]. Semin Oncol, 2008,35 ( 1 ) : 33-40.
  • 8Ben Hamida A, Labidi IS, Mrad K,et al. Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin [ J ]. BMC Cancer, 2008,8 : 28.
  • 9Levine PH, Portera CC, Hoffman H J, et al. Evaluation oflymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer[J]. Clin Breast Cancer, 2012,12(4) :232-239.
  • 10yon Minckwitz G, Sinn HP, Raab G, et al. Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast[ J ]. Breast Cancer Res, 2008,10(2) :R30.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部